Patient Engagement Solutions Market

Patient Engagement Solutions Market by Component (Hardware, Software, Services), Delivery Mode (On Premise, Cloud), End User (Provider, Payer), Applications (Home Health, Financial Health), Therapeutic Area - Analysis and Global Forecast to 2025

Report Code: HIT 2767 Jul, 2020, by marketsandmarkets.com

[170 Pages Report] The patient engagement solutions market is projected to reach USD 19.3 billion by 2025 from USD 11.9 billion in 2020, at a CAGR of 10.1%. The growth of this market is driven by the implementation of government regulations and initiatives to promote patient-centric care, increasing demand for patient engagement solutions, and the increasing utilization of mobile health apps.-

Patient Engagement Solutions Market

Covid 19 impact of the Patient Engagement Solutions Market

Due to the COVID-19 outbreak, medical practices of all sizes are under immense pressure, and healthcare facilities across the globe have been overwhelmed by the large number of patients visiting them on a daily basis. The rising prevalence of coronavirus disease has driven the demand for accurate diagnosis and treatment devices in several countries across the globe. The COVID-19 pandemic has also increased the need for social distancing among physicians and patients, which has driven the demand for remote patient monitoring and telehealth solutions and the need for the accurate and timely exchange of patient health records. Various players in this market have introduced COVID-19- related features into their existing patient engagement solutions, which are being made available to users free of cost. This is leading to improved adoption of the solutions in current times.

Patient Engagement Solutions Market Dynamics

Drivers: Implementation of government regulations and initiatives to promote patient-centric care

Governments across the globe are implementing various regulations and initiatives to encourage the adoption of patient engagement solutions. For instance, in 2020, EU Health Ministers signed a declaration to collaborate and set up an eHealth common area that will allow for the free movement of electronic health records across Europe. The declaration also calls for eHealth to be made an integral part of the Europe 2020 strategy. In the US, the Patient Protection and Affordable Care Act (PPACA) or Affordable Care Act (ACA) PPACA, signed in March 2010, has resulted in the increasing number of stakeholders subscribing to patient engagement solutions. Improved reimbursement laws in emerging countries to drive market growth.

Restrains: Protection of patient information

Concerns over patient health data security are creating barriers in the transfer of this data among various stakeholders in the healthcare industry. This, in turn, is affecting patient engagement initiatives in various healthcare organizations and is limiting the adoption of patient engagement solutions among prospective end users.

Opportunities: Emerging Asian Countries:

A number of factors, such as the implementation of government initiatives supporting the adoption of HCIT solutions, rising government healthcare expenditure, and the presence of skilled IT experts in emerging Asian countries, such as China and India, are expected to support the growth of the patient engagement solutions market in Asia.

Challenges: High Cost of deployment

Healthcare IT systems are high-priced software solutions. Moreover, the maintenance and software update costs of these systems may be more than the price of the software. Support and maintenance services, which include software upgrades as per the changing user requirement, represent a recurring expenditure, which amounts to almost 30% of the total cost of ownership. The lack of internal IT expertise in the healthcare industry necessitates training for end users in order to maximize the efficiency of various healthcare IT solutions, thereby adding to the cost of ownership of the systems.

By component, the services segment accounted for the highest growth in 2019.

On the basis of component, the patient engagement solutions market is segmented into software, hardware, and services. The software segment is further segmented into standalone and integrated solutions. The software segment is expected to account for the largest share in this market however, services segment is said to grow at the highest rate due to the fact that the service component is indispensable in the application of deployed solutions.

The cloud based delivery ode of solutions is expected to grow at the highest CAGR in 2019.

On the basis of delivery mode, the patient engagement solutions market is segmented into on-premise and cloud-based solutions. The on premise based solutions accounted for the largest share in the market however cloud based solutions segment is expected to register the highest CAGR during the forecast period. The flexibility, scalability, and affordability offered by cloud-based solutions are supporting their growth in the patient engagement solutions market. Cloud-based solutions help healthcare organizations share and integrate information from different locations or systems in real-time.

Health management application of patient engagement solutions accounts for the largest share in 2019.

On basis of application, the patient engagement solutions market is segmented into health management, home health management, social and behavioral management, and financial health management. In 2019, the health management applications segment accounted for the largest share of the global patient engagement solutions market. The large share of this segment can be attributed to the increasing awareness among patients about the complexity of their disease conditions and their willingness to actively participate in maintaining their own health.

Providers account for the largest end user market in the patient engagement solutions market in 2019.

On the basis of end users, the patient engagement solutions market is segmented into providers, payers, patients, and other end users (including government bodies, employer groups, and pharmaceutical companies). In 2019, the providers segment accounted for the largest share of the global patient engagement solutions market. Providers are increasingly adopting patient engagement solutions to curtail rising healthcare costs, offer value-based care, and improve financial outcomes.

Chronic disease account for the largest therapeutic use market in the patient engagement solutions market in 2019.

Based on the therapeutic area, the patient engagement solutions market is segmented into chronic diseases, women’s health, fitness, and other therapeutic areas. In 2019, the chronic diseases segment accounted for the largest share of the global patient engagement solutions market. The large share of this segment can be attributed to the high burden of chronic diseases and the need to effectively manage these conditions while reducing the overall healthcare costs.

Asia Pacific accounts for the highest growth in the patient engagement solutions market during the forecast period.

Asia Pacific is expected to grow at the highest CAGR. The need for cost-effective and quality care, rising geriatric population, and the increasing prevalence of various chronic diseases are driving the growth of the patient engagement solutions market in the Asia Pacific. In addition, the current outbreak of COVID-19 in the Asia Pacific has resulted in the increased patient pool, especially in China and India. The growing patient volume, along with the rising need for accurate and timely diagnosis and treatment of this disease, will fuel the growth of the patient engagement solutions market in the APAC.

Patient Engagement Solutions Market  by Region

Key Players

McKesson Corporation (US), Allscripts (US), IBM (US), AdvancedMD (US), Cerner Corporation (US), Epic Systems Corporation (US) are the dominating players of the patient engagement solutions market.

Scope of the Report

Market size for years

2018-2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD Million)

Segments covered

By Component, By Delivery Mode, By Therapeutic Area, By End User, By Application and By region

Geographies covered

North America, Europe, Asia Pacific, ROW.

Companies covered

The major market players include McKesson Corporation (US), Allscripts (US), IBM (US), AdvancedMD (US), Cerner Corporation (US), Epic Systems Corporation (US).

The study categorizes the patient engagement solutions market based on the basis of By Component, By Delivery Mode, By Therapeutic Area, By End User, By Application and by region

By Component

  • Hardware
  • Software
  • Services

By Delivery Mode

  • On Premise
  • Cloud Based

By Application

  • Health Management
  • Home Health Management
  • Social and Behavioural Management
  • Financial Health Management

By End User

  • Providers
  • Payers
  • Patients
  • Other End Users

By Therapeutic Area

  • Chronic diseases
  • Women’s health
  • Fitness
  • Other therapeutic areas

By Region

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Rest of the World (RoW)

Recent Developments

  • In 2020, Get Real Health launched Talk With Your Doc, a telehealth solution that enables providers to manage their revenue-generating healthcare services and enables patient-provider relationships, especially during the COVID-19 pandemic.
  • In 2020, Orion Health has developed the first comprehensive pandemic outbreak monitoring platform in order to curb the spread of the COVID-19 virus. The Coronavirus Outbreak Solution engages patients in their homes, facilitates communication between quarantined patients and healthcare service providers, and maintains visibility of those recently discharged.
  • In 2020, BM and Wipro collaborated to launch an innovation center in India to build industry solutions leveraging cloud, artificial intelligence, machine learning, and the internet of things.
  • In 2019, BirdEye partnered with athenahealth through the athenahealth EHR Marketplace program. BirdEye is now available to athenahealth’s growing network of healthcare providers.
  • In 2019, Harris Healthcare acquired Uniphy Health Systems to extend its clinical software solution offerings and provide improved care coordination and physician and patient engagement through Uniphy’s platform.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 19)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
           1.5.1 SCOPE-RELATED LIMITATIONS
           1.5.2 METHODOLOGY-RELATED LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 24)
    2.1 RESEARCH DATA
    2.2 RESEARCH METHODOLOGY STEPS
           2.2.1 SECONDARY DATA
                    2.2.1.1 Secondary sources
           2.2.2 PRIMARY RESEARCH
                    2.2.2.1 Primary sources
                    2.2.2.2 Key insights from primary sources
    2.3 MARKET SIZE ESTIMATION METHODOLOGY
    2.4 MARKET ESTIMATION
    2.5 MARKET DATA ESTIMATION AND TRIANGULATION
    2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 34)

4 PREMIUM INSIGHTS (Page No. - 39)
    4.1 PATIENT ENGAGEMENT SOLUTIONS MARKET OVERVIEW
    4.2 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE & COUNTRY (2019)
    4.3 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY COMPONENT, 2020 VS. 2025
    4.4 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY DELIVERY MODE, 2020 VS. 2025
    4.5 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY APPLICATION, 2020 VS. 2025
    4.6 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY END USER, 2020 VS. 2025
    4.7 PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE, BY THERAPEUTIC AREA, 2020 VS. 2025

5 MARKET OVERVIEW (Page No. - 43)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care
                    5.2.1.2 Increasing adoption of patient engagement solutions
                    5.2.1.3 Rising number of collaborations and partnerships between stakeholders
                    5.2.1.4 Increasing utilization of mobile health apps
           5.2.2 RESTRAINTS
                    5.2.2.1 Requirement of investments in infrastructure for implementing patient engagement solutions
                    5.2.2.2 Protection of patient information
                    5.2.2.3 Lack of interoperability
                    5.2.2.4 Dearth of skilled IT professionals in the healthcare industry
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging Asian countries
                    5.2.3.2 Wearable health technology
                    5.2.3.3 Cloud-based models
           5.2.4 CHALLENGES
                    5.2.4.1 High cost of deployment
                    5.2.4.2 Lack of health literacy
    5.3 IMPACT OF COVID-19 ON THE PATIENT ENGAGEMENT SOLUTIONS MARKET

6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT (Page No. - 50)
    6.1 INTRODUCTION
    6.2 HARDWARE
           6.2.1 HARDWARE SOLUTIONS PROVIDES INTERACTIVE EXPERIENCE FOR PATIENTS AND THEIR FAMILIES
    6.3 SOFTWARE
           6.3.1 STANDALONE SOFTWARE
                    6.3.1.1 Standalone software are traditional software installed in client systems
           6.3.2 INTEGRATED SOFTWARE
                    6.3.2.1 Integrated software is the largest & fastest-growing segment of the PES software market
    6.4 SERVICES
           6.4.1 THE SERVICES SEGMENT IS ESTIMATED TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD

7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE (Page No. - 56)
    7.1 INTRODUCTION
    7.2 ON-PREMISE SOLUTIONS
           7.2.1 ON-PREMISE SOLUTIONS WILL CONTINUE TO DOMINATE THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN THE FORECAST PERIOD
    7.3 CLOUD-BASED SOLUTIONS
           7.3.1 CLOUD-BASED SOLUTIONS ARE PROJECTED TO REGISTER THE HIGHEST GROWTH DURING THE STUDY PERIOD

8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER (Page No. - 60)
    8.1 INTRODUCTION
    8.2 PROVIDERS
           8.2.1 PROVIDERS ARE THE LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS
    8.3 PAYERS
           8.3.1 HEALTHCARE PAYER INDUSTRY IS WITNESSING CHANGES IN TERMS OF LEGISLATION AND COMPETITION
    8.4 PATIENTS
           8.4.1 INCREASING PARTICIPATION OF PATIENTS IN THEIR OWN CARE TO SUPPORT MARKET GROWTH
    8.5 OTHER END USERS

9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION (Page No. - 65)
    9.1 INTRODUCTION
    9.2 HEALTH MANAGEMENT
           9.2.1 HEALTH MANAGEMENT IS THE LARGEST & FASTEST-GROWING APPLICATION SEGMENT OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET
    9.3 HOME HEALTH MANAGEMENT
           9.3.1 GROWING PREFERENCE OF HOME HEALTH CARE TO SUPPORT MARKET GROWTH
    9.4 SOCIAL & BEHAVIORAL MANAGEMENT
           9.4.1 GROWING POPULARITY OF SOCIAL MEDIA WILL DRIVE MARKET GROWTH
    9.5 FINANCIAL HEALTH MANAGEMENT
           9.5.1 FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS

10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA (Page No. - 70)
     10.1 INTRODUCTION
     10.2 CHRONIC DISEASES
             10.2.1 CARDIOVASCULAR DISEASE
                       10.2.1.1 Cardiovascular disease is the leading cause of death globally
             10.2.2 DIABETES
                       10.2.2.1 High burden of diabetes to support market growth
             10.2.3 OBESITY
                       10.2.3.1 Rising prevalence of obesity to drive market growth
             10.2.4 OTHER CHRONIC DISEASES
     10.3 WOMEN’S HEALTH
             10.3.1 IMPROVED AWARENESS TO DRIVE MARKET GROWTH
     10.4 FITNESS
             10.4.1 INCREASING PREFERENCE FOR A HEALTHY LIFESTYLE TO SUPPORT MARKET GROWTH
     10.5 OTHER THERAPEUTIC AREAS

11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION (Page No. - 78)
     11.1 INTRODUCTION
     11.2 NORTH AMERICA
             11.2.1 US
                       11.2.1.1 The US is the largest market for patient engagement solutions
             11.2.2 CANADA
                       11.2.2.1 Growing need for cost containment to propel market growth
     11.3 EUROPE
             11.3.1 GERMANY
                       11.3.1.1 Germany is the largest market for patient engagement solutions
            in Europe 90
             11.3.2 FRANCE
                       11.3.2.1 Digital health insurance startups in France to support market growth
             11.3.3 UK
                       11.3.3.1 Favorable government initiatives to drive market growth
             11.3.4 SPAIN
                       11.3.4.1 Data security concerns to hamper the market growth
             11.3.5 ITALY
                       11.3.5.1 Growing burden of chronic diseases is driving the demand for patient engagement solutions in the country
             11.3.6 REST OF EUROPE (ROE)
     11.4 ASIA PACIFIC
             11.4.1 JAPAN
                       11.4.1.1 Rising geriatric population in Japan to support market growth
             11.4.2 CHINA
                       11.4.2.1 China to register the highest growth in the patient engagement solutions market
             11.4.3 INDIA
                       11.4.3.1 High burden of chronic diseases to support market growth
             11.4.4 REST OF ASIA PACIFIC (ROAPAC)
     11.5 REST OF THE WORLD
             11.5.1 LATIN AMERICA
                       11.5.1.1 Developments in healthcare infrastructure to support market growth
             11.5.2 MIDDLE EAST & AFRICA
                       11.5.2.1 Rising government support to drive market growth

12 COMPETITIVE LANDSCAPE (Page No. - 123)
     12.1 OVERVIEW
     12.2 MARKET EVALUATION FRAMEWORK
     12.3 MARKET RANKING
     12.4 KEY MARKET DEVELOPMENTS
             12.4.1 PRODUCT LAUNCHES
             12.4.2 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS
             12.4.3 ACQUISITIONS

13 COMPANY EVALUATION MATRIX & COMPANY PROFILES (Page No. - 128)
     13.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
             13.1.1 STAR
             13.1.2 EMERGING LEADERS
             13.1.3 EMERGING COMPANIES
             13.1.4 PERVASIVE
     13.2 COMPANY PROFILES
             13.2.1 MCKESSON CORPORATION
                       13.2.1.1 Business overview
                       13.2.1.2 Products offered
                       13.2.1.3 Recent developments
             13.2.2 ALLSCRIPTS HEALTHCARE, LLC
                       13.2.2.1 Business overview
                       13.2.2.2 Products offered
                       13.2.2.3 Recent developments
             13.2.3 IBM
                       13.2.3.1 Business overview
                       13.2.3.2 Products offered
                       13.2.3.3 Recent developments
             13.2.4 ATHENAHEALTH
                       13.2.4.1 Business overview
                       13.2.4.2 Products offered
                       13.2.4.3 Recent developments
             13.2.5 ORION HEALTH
                       13.2.5.1 Business overview
                       13.2.5.2 Products offered
                       13.2.5.3 Recent developments
             13.2.6 CERNER CORPORATION
                       13.2.6.1 Business overview
                       13.2.6.2 Products offered
                       13.2.6.3 Recent developments
             13.2.7 GETWELLNETWORK, INC.
                       13.2.7.1 Business overview
                       13.2.7.2 Products offered
                       13.2.7.3 Recent developments
             13.2.8 LINCOR SOLUTIONS
                       13.2.8.1 Business overview
                       13.2.8.2 Products offered
             13.2.9 MEDHOST
                       13.2.9.1 Business overview
                       13.2.9.2 Products offered
                       13.2.9.3 Recent developments
               13.2.10 HARRIS HEALTHCARE
                          13.2.10.1 Business overview
                          13.2.10.2 Products offered
                          13.2.10.3 Recent developments
               13.2.11 GET REAL HEALTH
                          13.2.11.1 Business overview
                          13.2.11.2 Products Offered
                          13.2.11.3 Recent developments
               13.2.12 ONEVIEW HEALTHCARE
                          13.2.12.1 Business overview
                          13.2.12.2 Products offered
                          13.2.12.3 Recent developments
               13.2.13 ADVANCEDMD
                          13.2.13.1 Business overview
                          13.2.13.2 Products offered
                          13.2.13.3 Recent developments
               13.2.14 CUREMD HEALTHCARE
                          13.2.14.1 Business overview
                          13.2.14.2 Products offered
                          13.2.14.3 Recent developments
               13.2.15 EPIC SYSTEMS CORPORATION
                          13.2.15.1 Business overview
                          13.2.15.2 Products offered
                          13.2.15.3 Recent developments
               13.2.16 MEDITECH
                          13.2.16.1 Business overview
                          13.2.16.2 Products offered
                          13.2.16.3 Recent developments
               13.2.17 KAREO
                          13.2.17.1 Business overview
                          13.2.17.2 Products offered
               13.2.18 ECLINICAL WORKS
                          13.2.18.1 Business overview
                          13.2.18.2 Products offered
                          13.2.18.3 Recent developments
               13.2.19 SYMPHONYCARE
                          13.2.19.1 Business overview
                          13.2.19.2 Products offered
                          13.2.19.3 Recent developments
               13.2.20 IQVIA
                          13.2.20.1 Business overview
                          13.2.20.2 Products Offered
                          13.2.20.3 Recent developments
               13.2.21 VIVIFY HEALTH
                          13.2.21.1 Business overview
                          13.2.21.2 Products offered
                          13.2.21.3 Recent developments
               13.2.22 COGNIZANT
                          13.2.22.1 Business overview
                          13.2.22.2 Product offered
               13.2.23 PATIENTSLIKEME
                          13.2.23.1 Business overview

14 APPENDIX (Page No. - 163)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS


LIST OF TABLES (129 Tables)

TABLE 1 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2018–2020
TABLE 2 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 3 HARDWARE SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 4 SOFTWARE SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 5 SOFTWARE SOLUTIONS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 6 STANDALONE SOFTWARE SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 INTEGRATED SOFTWARE SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 10 ON-PREMISE SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 CLOUD-BASED SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 13 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 14 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 16 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 18 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 19 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 PATIENT ENGAGEMENT SOLUTIONS FOR FINANCIAL HEALTH MANAGEMENT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 25 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2018–2025 (USD MILLION)
TABLE 26 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION, 2018–2025 (USD MILLION)
TABLE 27 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2018–2025 (USD MILLION)
TABLE 28 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY REGION, 2018–2025 (USD MILLION)
TABLE 31 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2018–2025 (USD MILLION)
TABLE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 33 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET,  BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 39 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 40 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 41 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 42 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 43 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 44 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 45 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 46 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 47 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 48 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 51 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 52 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 53 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 54 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 55 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 56 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 57 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 58 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 59 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 60 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 61 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 62 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 63 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 64 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 65 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 66 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 67 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 68 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 69 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 70 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 71 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 72 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 73 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 74 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 75 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 76 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 77 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 78 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 79 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 80 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 81 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 82 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 83 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 84 ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 85 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 86 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 87 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 88 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 89 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 90 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 91 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 92 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 93 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 94 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 95 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 96 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 97 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 98 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 99 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 100 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 101 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 102 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 103 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 104 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 105 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 106 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 107 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 108 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 109 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 110 ROAPAC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 111 REST OF THE WORLD: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 112 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 113 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 114 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 115 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 116 ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 117 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 118 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 119 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 120 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 121 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 123 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 124 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 125 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 126 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2018–2025 (USD MILLION)
TABLE 127 PRODUCT LAUNCHES, JANUARY 2017–JUNE 2020
TABLE 128 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS, JANUARY 2017–JUNE 2020
TABLE 129 ACQUISITIONS, JANUARY 2017–JUNE 2020
 
 
LIST OF FIGURES (34 Figures)
 
FIGURE 1 RESEARCH METHODOLOGY: PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 5 RESEARCH METHODOLOGY: MARKET ESTIMATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2020 VS. 2025 (USD MILLION)
FIGURE 8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2020 VS. 2025 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 13 GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC CARE TO DRIVE MARKET GROWTH
FIGURE 14 ON-PREMISE SOLUTIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019
FIGURE 15 SOFTWARE SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2020
FIGURE 16 ON-PREMISE SOLUTIONS WILL ACCOUNT FOR THE LARGEST MARKET SHARE IN 2025
FIGURE 17 HEALTH MANAGEMENT APPLICATIONS DOMINATE THE PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 18 HEALTHCARE PROVIDERS ARE THE LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS
FIGURE 19 CHRONIC DISEASES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025
FIGURE 20 PATIENT ENGAGEMENT SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 21 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIGURE 22 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIGURE 23 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS WERE THE MOST WIDELY ADOPTED GROWTH STRATEGIES
FIGURE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET RANKING, BY KEY PLAYER, 2019
FIGURE 25 KEY DEVELOPMENTS BY PROMINENT PLAYERS IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 26 COMPANY EVALUATION MATRIX: PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 27 MCKESSON CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 28 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2019)
FIGURE 29 IBM: COMPANY SNAPSHOT (2019)
FIGURE 30 CERNER CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 31 ONEVIEW HEALTHCARE: COMPANY SNAPSHOT (2019)
FIGURE 32 MEDITECH: COMPANY SNAPSHOT (2019)
FIGURE 33 IQVIA: COMPANY SNAPSHOT (2019)
FIGURE 34 COGNIZANT: COMPANY SNAPSHOT (2019)

This study involved the four major activities in estimating the size of the Patient Engagement Solutions market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Healthcare Information and Management Systems Society, American Medical Group Association, Agency for Healthcare Research & Quality, Health Research & Educational Trust, American Hospital Association, International Association of Health Policy, Institute of Population and Public Health, Public Health Agency of Canada, WHO, OECD, Expert Interviews, and MarketsandMarkets Analysis.

Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the digital pathology market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the digital pathology market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents is provided below:

Patient Engagement Solutions Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The bottom-up approach has been used to estimate and validate the size of the automotive airbags & seatbelts market.

  • In this approach, the vehicle production statistics for each vehicle type have been considered at a country and regional level.
  • Extensive secondary and primary research has been carried out to understand the global market scenario for various types of airbags and seatbelts used in the automotive industry.
  • Several primary interviews have been conducted with key opinion leaders related to automotive safety system development, including key OEMs and Tier I suppliers.
  • Qualitative aspects such as market drivers, restraints, opportunities, and challenges have been taken into consideration while calculating and forecasting the market size.

Global Patient Engagement Solutions Market Size: Bottom- Up approach

Patient Engagement Solutions Market  Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides, in the food, feed, pharmaceutical, nutraceutical, and personal care industries.

Objectives of the Study

  • To define, describe, and forecast the global patient engagement solutions market on the basis of component, delivery mode, application, end user, therapeutic area, and region
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall patient engagement solutions market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically analyze the market structure and profile the key players of the patient engagement solutions market and comprehensively analyze their core competencies2
  • To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
  • To track and analyze competitive developments such as product launches, acquisitions, partnerships, agreements, and collaborations in the patient engagement solutions market during the forecast period

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of automotive airbags & seatbelts market
  • Profiling of additional market players (up to 3)
  • Country-level analysis of EV and Off-Highway Segment
COVID-19

Get in-depth analysis of the COVID-19 impact on the Patient Engagement Solutions Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Patient Engagement Solutions Market

Request For Special Pricing
Report Code
HIT 2767
Published ON
Jul, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Patient Engagement Solutions Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home